D-0445-2025 Class II Ongoing

Recalled by KVK Tech, Inc. — Newtown, PA

FDA drug recall D-0445-2025 was initiated by KVK Tech, Inc. on May 9, 2025 and is designated Class II. Reason for recall: cGMP deviations The recall status is ongoing. Affected quantity: 9107 bottles.

Recall details

Product Type
Drugs
Report Date
May 28, 2025
Initiation Date
May 9, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9107 bottles

Product description

Indomethacin Extended-Release Capsules USP, 75 mg, 100-count bottle, Rx only, Mfd. By: KVK-Tech, Inc., Newtown, PA, 18940, Made in USA, NDC 10702-016-01.

Reason for recall

cGMP deviations

Distribution pattern

Nationwide

Code information

Lot#: 18400A, Exp 7/31/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0445-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0445-2025. Report a data issue: hello@regdatalab.com.